Search

everythinglearnresearchcommunity

for

Search:↓

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Isotretinoin may effectively treat hereditary hypotrichosis simplex, a rare hair loss condition.

Using polyethylenimine-DNA to deliver the hTERT gene can stimulate hair growth and may be useful in treating hair loss, but there could be potential cancer risks.

The woman was diagnosed with systemic lupus erythematosus (SLE) after initial misdiagnosis and improved with proper treatment.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

HAC and BAC improve skin targeting and reduce diffusion without causing irritation.

Entospletinib effectively prevents eye and skin GVHD in mice.

A mutation in the HR gene causes a rare form of irreversible hair loss in two Kashmiri families. Whole exome sequencing is effective for finding such mutations.

Cyproterone acetate effectively treats hirsutism and related conditions.

CARASIL, a rare genetic disorder, was confirmed in an Arabic woman, highlighting its rarity and need for stroke prevention.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Heparin-functionalized nanofabrics help heal wounds effectively and safely without scars in 14 days.

Aptamers can improve wound healing and promote hair growth.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Topical finasteride may help treat facial hirsutism in women.

A new delivery system makes Curcumin more effective and safer against viruses.

HB-EGF boosts the hair growth ability of stem cells, making it a potential hair loss treatment.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

High-content screening is useful for finding new treatments for rare diseases and has led to FDA-approved drugs.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.